Richard Bertz

7PUBLICATIONS
16CO-AUTHORS
Molecular medicineAir pollution modelling and controlPharmacogenomicsWastewater treatment processesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 04, 2025
Population Pharmacokinetic Modeling of the Oral Calcitonin Gene-Related Peptide Receptor Antagonist Rimegepant in Adults.

Craig M Comisar, Jim H Hughes, Jose Francis

|Nov 27, 2024
Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.

Rajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia

|Nov 04, 2024
Population pharmacokinetic modeling of zavegepant, a calcitonin gene-related peptide receptor antagonist, in healthy adults and patients with migraine.

Craig M Comisar, Jose Francis, Jim H Hughes

|Sep 30, 2024
Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects.

Rajinder Bhardwaj, Mary Donohue, Jennifer Madonia

|Jul 17, 2024
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment.

Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia

|May 30, 2024
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval.

Jim H Hughes, Richard Bertz, Rajinder Bhardwaj

Pageof 2